Zusammenfassung
Unter den positiv inotrop wirkenden Pharmaka sind die Herzglykoside zur langfristigen Therapie der Myokardinsuffizienz nach wie vor die wichtigsten Substanzen. Ihr Wirkungsmechanismus ist im einzelnen nicht bekannt (Lit. s. Akera und Brody 1978, Lüllmann und Peters 1979, Lee et al. 1980, Noble 1980, Greeff 1981). Es besteht Einigkeit, daß sie letztlich in der Zelle zu einer Zunahme der Konzentration an Ca++ ([Ca++]i) fuhren, das mit den kontraktilen Proteinen reagiert. Unklar ist jedoch, wie dies geschieht. Es besteht ebenfalls Einigkeit, daß die Herzglykoside mit der (Na+ + K+)-ATPase reagieren. Eine Hypothese besagt nun, daß eine Hemmung dieses Enzyms eine Steigerung der intrazellulären Na+-Konzentration bewirkt und daß es infolgedessen über eine Änderung des transmembranären Na+/Ca++-Austausches zu einer Steigerung der [Ca++]i kommt. Andere Autoren nehmen an, daß eine derartige Hemmung der (Na+ + K+)-ATPase nur bei toxischen Herzglykosidwirkungen eine Rolle spielt. Sie gehen davon aus, daß die Herzglykoside in „therapeutischer“ Konzentration durch die Reaktion mit der (Na+ + K+)-ATPase zu einer Labilisierung der Ca++-Bindung in der Zellmembran und dadurch während der Erregung zu einer Verbesserung der Ca++-Freisetzung aus sarkolemmalen Ca++-Speichern führen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Akera, T., Brody, T.M.: The role of Na+, K+-ATPase in the inotropic action of digitalis. Pharmacol. Rev. 29: 187–220 (1978).
Alousi, A.A., Farah, A.E., Lesher, G.Y., Opalka, C.J.: Cardiotonic activity of amrinone — Win 40680 (5-amino-3,4’-bipyridin-6(lH)-one). Ore. Res. 45: 666–677 (1979).
Avenhaus, H., Lüderitz, B., Strauer, B.E., Boite, H.-D., Riecker, G.: Kardiale Wirkungen von Glucagon. Dtsch. Med. Wschr. 96: 702–707 (1971).
Bassingthwaighte, J.B., Reuter, H.: Calcium movements and excitation-contraction coupling in cardiac cells. In: Electrical phenomena in the heart (W.C. de Mello, ed.), pp. 353–395. New York, London: Academic Press 1972.
Benfey, B.G.: Cardiac α adrenoceptors. Can. J. Physiol. Pharmacol. 58: 1145–1157 (1980).
Benotti, J.R., Grossman, W., Braunwald, E., Carabello, B.A.: Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Circulation 62: 28–34 (1980).
Benotti, J.R., Grossman, W., Braunwald, E., Davolos, D.D., Alousi, A.A.: Hemodynamic assessment of amrinone. A new inotropic agent. N. Engl. J. Med. 299: 1373–1377 (1978).
Blinks, J.R., Olson, C.B., Jewell, B.R., Braveny, P.: Influence of caffeine and other methylxanthines on mechanical properties of isolated mammalian heart muscle. Evidence for a dual mechanism of action. Circ. Res. 30: 367–392 (1972).
Bolton, T.B.: Mechanisms of action of transmitters and other substances on smooth muscle. Physiol. Rev. 59:606–718 (1979).
Bourdillon, P.D.V., Dawson, J.R., Foale, R.A., Timmis, A.D., Poole-Wilson, P.A., Sutton, G.C: Salbutamol in treatment of heart failure. Br. Heart J. 43: 206–210 (1980).
Bruckner, R., Hackbarth, I., Meinertz, T., Schmelzle, B., Scholz, H.: The positive inotropic effect of phenylephrine in the presence of propranolol. Increase in time to peak force and in relaxation time without increase in c-AMP. Naunyn-Schmiedeberg’s Arch. Pharmacol. 303: 205–211 (1978).
Chapman, R.A.: Excitation-contraction coupling in cardiac muscle. Prog. Biophys. Mol. Biol. 35: 1–52 (1980).
Colucci, W.S., Alexander, R.W., Mudge, G.H., Rude, R.E., Holman, B.L., Wynne, J., Grossman, W., Braunwald, E.: Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure. Am. Heart J. 102: 564–568 (1981).
Cyran, J., Bolte, H.-D.: Kombinierte Infusion von Nitroprussid-Natrium und Dobutamin zur Behandlung der hochgradigen Linksherzinsuffizienz bei koronarer Herzkrankheit. Klin. Wschr. 57: 883–891 (1979).
Dahmen, M., Greeff, K.: Analysis of the positive-inotropic activity of the benzimidazole derivate AR-L 115 BS in isolated guinea pig atria. Arzneim.-Forsch. (Drug Res.) 31: 161–165 (1981).
Dawson, J.R., Canepa-Anson, R., Kuan, P., Whitaker, N.H.G., Carnic, J., Warnes, C, Reuben, S.R., Poole Wilson, P.A., Sutton, G.C.: Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses. Br. Med. J. 282: 1423–1426 (1981).
Diederen, W., Kadatz, R.: Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS. Arzneim.Forsch. (Drug Res.) 31: 141–146 (1981).
Diederen, W., Weisenberger, H.: Studies on the mechanism of the positive-inotropic action of AR-L 115 BS, a new cardiotonic drug. Arzneim.-Forsch. (Drug Res.) 31: 177–182 (1981).
Dönges, C, Heitmann, M., Jungbluth, H., Meinertz, T., Schmelzle, B., Scholz, H.: Effectiveness of theophylline to increase cyclic AMP levels and force of contraction in electrically paced guinea-pig auricles. Comparison withisoprenaline, calcium andouabain. Naunyn-Schmiedeberg’s Arch. Pharmacol. 301: 87–97 (1977).
Drummond, G.I., Severson, D.L.: Cyclic nucleotides and cardiac function. Circ. Res. 44: 145–153 (1979).
Fabiato, A., Fabiato, F.: Calcium release from the sarcoplasmic reticulum. Circ. Res. 40: 119–129 (1977).
Farah, A.E., Alousi, A.A.: New cardiotonic agents: a search for digitalis substitute. Life Sci. 22: 1139–1148 (1978).
Goldberg, L.I.: Dopamine — Clinical uses of an endogenous catecholamine. N. Engl. J. Med. 291: 707–710 (1974).
Goldberg, L.I., Hsieh, Y.-Y., Resnekov, L.: Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine. Prog. Cardiovasc. Dis. 19: 327–340 (1977).
Greeff, K. (ed.): Cardiac Glycosides. Handbook of Experimental Pharmacology 56/1, pp. 1–682. Berlin, Heidelberg, New York: Springer 1981.
Hackbarth, L, Schmitz, W., Scholz, H., Erdmann, E., Krawietz, W., Philipp, G.: Stimulatory effect of vanadate on cyclic AMP levels in cat papillary muscle. Biochem. Pharmacol. 29: 1429–1432 (1980).
Hedberg, A., Minneman, K.P., Molinoff, P.B.: Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart. J. Pharmacol. Exp. Ther. 213: 503–508 (1980).
Herzig, J.W., Feüe, K., Rüegg, J.C.: Activating effects of AR-L 115 BS on the Ca2+ sensitive force, stiffness and unloaded shortening velocity (Vmax) in isolated contractile structures from mammalian cardiac muscle. Arzneim.-Forsch. (Drug Res.) 31: 188–191 (1981).
Honerjäger, P., Schäfer-Körting, M., Reiter, M.: Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence. Naunyn-Schmiedeberg’s Arch. Pharmacol. 318: 112–120 (1981).
Irmer, M., Wollschläger, H., Just, H.: Behandlung der schweren Herzinsuffizienz mit dem Beta-Stimulator Fenoterol. Klin. Wochenschr. 59: 639–645 (1981).
Katz, A.M.: Physiology of the heart. New York: Raven Press 1977.
Katz, A.M.: A new inotropic drug: its promise and a caution. N. Engl. J. Med. 299: 1409–1410 (1978).
Katz, A.M.: Role of the contractile proteins and sarcoplasmic reticulum in the response of the heart to catecholamines: An historical review. Adv. Cycl. Nucleot. Res. 11: 303–343 (1979).
Katz, A.M.: Relaxing effects of catecholamines in the heart. Trends Pharmacol. Sci. 1: 434–436 (1980).
Kerr, C.R.: Hemodynamic effects of oral salbutamol in patients with severe left ventricular failure. Circulation 60 (Suppl. II): 11–41 (1979).
Kirlin, P.C., Pitt, B.: Hemodynamic effects of intravenous prenalterol in severe heart failure. Am. J. Cardiol. 47: 670–675 (1981).
Kones, R.J., Phillips, J.H.: Glucagon: present status in cardiovascular disease. Clin. Pharmacol. Ther. 12: 427–444 (1971).
Korth, M.: Effects of several phosphodiesterase — inhibitors on guinea-pig myocardium. NaunynSchmiedeberg’s Arch. Pharmacol. 302: 77–86 (1978).
Krause, E.-G., Wollenberger, A.: Cyclic nucleotides and heart. In: Cyclic 3’,5’-Nucleotides: Mechanisms of Action (H. Cramer, J. Schultz, eds.), pp. 229–250. London: Wiley 1977.
Kruse, E., Scholz, H.: Effect of theophylline on myocardial adenylate cyclase activity. Experientia 34: 504–505 (1978).
Kukovetz, W.R., Pöch, G., Holzmann, S.: Cyclic nucleotides and relaxation of vascular smooth muscle. In: Vasodilatation (P.M. Vanhoutte, I. Leusen, eds.), pp. 339–353. New York: Raven Press 1981.
Langer, G.A.: The structure and function of the myocardial cell surface. Am. J. Physiol. 235: H461–468 (1978).
Langer, G.A.: The role of calcium in the control of myocardial contractility: An update. J. Mol. Cell. Cardiol. 12: 231–239 (1980).
Lee, C.O., Kang, D.H., Sokol, J.H., Lee, K.W.: Relation between intracellular Na ion activity and tension of sheep cardiac Purkinje fibers exposed to dihydroouabain. Biophys. J. 29: 315–330 (1980).
LeJemtel, T.H., Keung, E., Sonnenblick, E.H., Ribner, H.S., Matsumuto, M., Davis, R., Schwartz, W., Alousi, A.A., Davolos, D.: Amrinone: A new nonglycosidic, non-adrénergie cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation 59: 1098–1104 (1979).
Limbourg, P., Just, H., Kersting, F., Lang, K.F.: Kardiovaskuläre Effekte von Dobutamin. Klin. Wschr. 56: 551–557 (1978).
Liillmann, H., Peters, T.: Action of cardiac glycosides on the excitation-contraction coupling in heart muscle. A new concept. Progr. Pharmacol. 2/2: 1–58 (1979).
Lüttgau, H.C., Glitsch, H.G.: Membrane physiology of nerve and muscle fibres. Forschr. Zool. 24: 1–132 (1976).
Mason, D.T., Braunwald, E., Cohn, J.N. (eds.): New modalities in the management of heart failure. Am. Heart J. 102: 485–642 (1981).
Mason, D.T., Awan, N.A., Amsterdam, E.A., Lee, G., Joye, J.A., Foerster, J.M., Laslett, L.J., Low, R.I., DeMaria, A.N.: New therapeutic approaches to the failing heart: Recent advances in vasodilators, cardiotonics, and mechanical circulatory assistance. Adv. Heart. Dis. 3: 403–446 (1980).
Millard, R.W., Dubé, G., Grupp, G., Grupp, I., Alousi, A., Schwartz, A.: Direct vasodilator and positive inotropic actions of amrinone. J. Mol. Cell. Cardiol. 12:647–652 (1980).
Miura, Y., Inui, J., Imamura, H.: Alpha-adrenoceptormediated restoration of calcium-dependent potential in the partially depolarized rabbit papillary muscle. Naunyn-Schmiedeberg’s Arch. Pharmacol. 301:201–205 (1978).
Mugelli, A., Ledda, F., Mantelli, L., Torrini, M., Maccioni, T.: Studies on the positive inotropic effect of dopamine in the guinea-pig heart. NaunynSchmiedeberg’s Arch. Pharmacol. 301: 49–55 (1977).
Nimmo, H.G., Cohen, P.: Hormonal control of protein phosphorylation. Adv. Cycl. Nucleot. Res. 8: 145–266 (1977).
Noble, D.: Mechanism of action of therapeutic levels of cardiac glycosides.Cardiovasc. Res. 14:495–514 (1980).
Ochs, H.R., Bodem, G.: Alternativen zur Digitalistherapie? Dtsch. Med. Wschr. 106: 583–586 (1981).
Oltmanns, D., Wester, H.-A., Stein, R.: Echokardiographisch ermittelte Dosis-Wirkungs-Beziehung von Prenalterol. Z. Kardiol. 70: 394–398 (1981).
Opie, L.H.: Drugs and the heart. V. Digitalis and sympathomimetic stimulants. Lancet 1: 912–918 (1980).
Osnes, J.-B., Skomedal, T., 0ye, L: On the role of cyclic nucleotides in the heart muscle contraction and relaxation. Progr. Pharmacol. 4: 47–62 (1980).
Owen, D.A.A.: Histamine receptors in the cardiovascular system. Gen. Pharmae. 8: 141–156 (1977).
Parmley, W.W.:The role ofglucagonin cardiac therapy. N. Engl. J. Med. 285: 801–802 (1971).
Piepenbrock, S., Hempelmann, G., Reichelt, W., Stegmann, Th.: Hämodynamische und selektive vaskuläre Effekte von Dobutamin während und nach herzchirurgischen Eingriffen. Anaesthesist 28: 307–315 (1979).
Piepenbrock, S., Reichelt, W., Zenz, M., Scitz, W., Sikalieh, E.: Prenalterol (CGP 7760 B), ein neuer kardioselektiver ßj-Rezeptoren-Agonist. Anaesthesist 30: 118–123 (1981).
Reinhardt, D.: Herzwirkungen von Histamin. Differenzierung unterschiedlicher Rezeptoren, Physiologie und Biochemie des Wirkmechanismus. Anaesthesist 28: 67–77 (1979).
Reinhardt, D., Schmidt, U., Brodde, O.-E., Schümann, HJ.: H,-und H2-receptor mediated responses to histamine on contractility and cyclic AMP of atrial and papillary muscles from guinea-pig hearts. Agents/Actions 7: 1–12 (1977).
Reiter, M.: Drugs and heart muscle. Annu. Rev. Pharmacol. 12: 111–124 (1972).
Reuter, HL: Divalent cations as charge carriers in excitable membranes. Progr. Biophys. Mol. Biol. 26: 1–43 (1973).
Reuter, H.: Localization of beta adrenergic receptors, and effects of noradrenaline and cyclic nucleotides on action potentials, ionic currents and tension in mammalian cardiac muscle. J.Physiol. (Lond.) 242: 429–451 (1974a).
Reuter, H.: Exchange of calcium ions in the mammalian myocardium. Mechanisms and physiological significance. Circ. Res. 34: 599–605 (1974b).
Reuter, H., Scholz, H.: The regulation of the calcium conductance of cardiac muscle by adrenaline. J. Physiol. (Lond.) 264: 49–62 (1977).
Rodgers, R.L., MacLeod, K.M., McNeill, J.H.: Responses of rat and guinea pig hearts to glucagon. Lack of evidence for a dissociation between changes in myocardial cyclic 3’,5’-adenosine monophosphate and contractility. Circ. Res. 49: 216–225 (1981).
Rönn, O., Johnsson, G., Lundborg, P.: Interaction in healthy volunteers between prenalterol, a selective β1-adrenoceptor agonist, and metoprolol or propranolol. J. Cardiovasc. Pharmacol. 3: 477–484 (1981).
Rude, R.E., Turi, Z., Brown, E.J., Lorell, B.H., Colucci, W.S., Mudge, G.H., Taylor, C.R., Grossman, W.: Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure. Circulation 64: 139–145 (1981).
Sanehez-Chapula, J.: Differential effects of histamine on left and right guinea-pig atria. Eur. J. Pharmacol. 74: 253–256 (1981).
Schmitz, W., Hackbarth, I., Scholz, H., Wetzel, E.: Effects of vanadate on the c-AMP system of the heart. Basic Res. Cardiol. 75: 438–443 (1980).
Scholz, H.: Effects of beta-and alpha-adrenoceptor activators and adrenergic transmitter releasing agents on the mechanical activity of the heart. Handbook of Experimental Pharmacology Vol. 54/1, Adrenergic activators and inhibitors, Part I (L. Szekeres, ed.), pp. 651–733. Berlin, Heidelberg, New York: Springer 1980.
Scholz, H.: On the mechanism of action of theophylline on the heart and other organs. In: Methods in Clinical Pharmacology, Vol. 4, Theophylline and other Methylxanthines (N. Rietbrock, B.G. Woodcock, A.H. Staib, eds.), pp. 99–105. Braunschweig/Wiesbaden: Vieweg 1982.
Scholz, H., Bruckner, R.: Effects of alpha-adrenoceptor stimulating agents on cardiac mechanical and electrophysiological properties. Abstracts 8th International Congress of Pharmacology, p. 512, Tokyo 1981.
Schümann, HJ.: Are there a-adrenoceptors in the mammalian heart? Trends Pharmacol. Sci. 1: 195–197 (1980).
Schümann, HJ., Motomura, S., Endoh, M., Brodde, O.-E.: Comparison of the mechanisms underlying the positive inotropic actions of dopamine, adrenaline and isoprenaline on the isolated rabbit papillary muscle. Naunyn-Schmiedeburg’s Arch. Pharmacol. 297: 257–267 (1977).
Sharma, B., Goodwin, J.F.: Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle. Circulation 58: 449–460 (1978).
Sharma, B., Hoback, J., Francis, G.S., Hodges, M., Asinger, R.W., Cohn, J.N., Taylor, C.R.: Pirbuterol: A new oral sympathomimetic amine for the treatment of congestive heart failure. Am. Heart J. 102: 533–541 (1981).
Slutsky, R., Hooper, W., Gerber, K., Curtis, G., Karliner, J., Ashburn, W.: The effect of terbutaline on left ventricular function and size. Am. J. Cardiol. 45:412(1980).
Sobel, B.E., Mayer, S.E.; Cyclic adenosine monophosphate and cardiac contractility. Circ. Res. 32: 407–414 (1973).
Sonnenblick, E.H., Frishman, W.H., Le Jemtel, T.H.: Dobutamine: A new synthetic cardioactive sympathetic amine. N. Engl. J. Med. 300: 17–22 (1979).
Sulakhe, P.V., St. Louis, P.J.: Passive and active calcium fluxes across plasma membranes. Prog. Biophys. Mol. Biol. 35: 135–195 (1980).
Sutherland, E.W., Robison, G.A., Butcher, R.W.: Some aspects of the biological role of adenosine 3’,5’ monophosphate (cyclic AMP). Circulation 37: 279–306 (1968).
Symposium über AR-L 115 BS (Vardax®). Arzneim.Forsch. (Drug Res.) 31: 129–278 (1981).
Taylor, C.R., Baird, J.R.C., Blackburn, K.J., Cambridge, D., Constantine, J.W., Ghaly, M.S., Hayden, M.L., Mcllhenny, H.M., Moore, P.F., Olukotun, A.-Y., Pullman, L.G., Salsburg, D.S., Saxton, C.A.P.D., Shevde, S.: Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure. Am. Heart J. 102: 515–532 (1981).
Tsien, R.W.: Cyclic AMP and contractile activity in heart. Adv. Cycl. Nucleot. Res. 8: 363–420 (1977).
Verma, S.C., McNeill, J.H.: Cardiac histamine receptors and cyclic AMP. Life Sci. 19: 1797–1802 (1976).
Verma, S.C., McNeill, J.H.: Cardiac histamine receptors: differences between left and right atria and right ventricle. J. Pharmacol. Exp. Ther. 200: 352–362 (1977).
Waagstein, F., Reiz, S., Ariniego, R., Hjalmarson, A.: Clinical results with prenalterol in patients with heart failure. Am. Heart J. 102: 548–554 (1981).
Williams, J.F.: New developments and therapeutic applications of cardiac stimulating agents. Am. J. Cardiol. 32: 491–496 (1973).
Winegrad, S.: Electromechanical coupling in heart muscle. In: Handbook of Physiology, Section 2, The Cardiovascular System, Vol. 1, The Heart (R.M. Berne, ed.), pp. 393–428. Bethesda: American Physiological Society 1979.
Wollenberger, A., Will, H.: Protein kinase — catalyzed membrane phosphorylation and its possible relationship to the role of calcium in the adrenergic regulation of cardiac contraction. Life Sci. 22: 1159–1178 (1978).
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1982 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Scholz, H. (1982). Zur Pharmakologie positiv inotrop wirkender Pharmaka. In: Schaper, W., Gottwik, M.G. (eds) Fortschritte in der Kardiologie. Tagung der Deutschen Gesellschaft für Herz- und Kreislaufforschung, vol 48. Steinkopff. https://doi.org/10.1007/978-3-642-85322-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-85322-7_12
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-0609-1
Online ISBN: 978-3-642-85322-7
eBook Packages: Springer Book Archive